galingolin
11 hours ago
Fibernan, We appreciate your willingness to contribute, but we must clarify that your inputs were unsolicited. While we acknowledge your intentions, we kindly request that you refrain from further involvement.Please understand that your continued presence, despite not being invited, is causing discomfort. We respectfully ask you to leave.
Fiberman
2 days ago
No, just an honest person posting facts. The only one. It's very amusing to me to see what is said. I do stand by my statement "most lied about stock", certainly on iHub.
This is from 2021:
For those still interested, hereβs what you need to know about the company.
MultiCell Technologies is a biopharmaceutical company that hasnβt posted any new info in years.
In fact, the companyβs been dormant for so long that its official website isnβt even in use by it anymore.
Instead, it has been snatched up and is being used for a German blog.
The company was founded in 1970 and of the last reporting only had two employees working for it.
Its headquarters is located in Woonsocket, R.I.
Gerald Newmin serves as the chairman, president CEO and CFO of the company.
Newmin is at least 86...
loophole lawyer
6 months ago
Grant G. Miller Joins Board of MultiCell Technologies Inc.
Published: Oct 23, 2012
SAN DIEGO, Oct. 22, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Grant G. Miller to its board of directors. Mr. Miller will replace Mr. Altig who will be stepping down to allow for this appointment.
Mr. Miller received his B.A. from Loma Linda University in Riverside, CA and an MBA; Finance from the University of San Diego, in San Diego, CA. Mr. Miller currently serves as Chief Financial & Operating Officer of Sandel Avionics and has previously served as Chief Financial Officer of Rapid Bridge, LLC, General Manager & Division Controller of Scubapro, Chief Financial Officer of USA Broadband, Inc., Chief Financial Officer & Senior VP Operations of Alitum, and held several positions with WorldXchange and Time Warner Cable, including International Director of Development in Spain and Portugal, Regional Vice President Finance, Corporate Mergers & Acquisitions Analyst, Manager, Finance and Information Systems and Financial Analysis.
Jerry Newmin, MultiCell's CEO, said, "Mr. Miller was chosen because of his diverse international financial experience and expertise. Mr. Miller brings experience that should help the Company increase values for our shareholders."
MultiCell is developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, and cancer. For more information about MultiCell Technologies, please visit http://www.multicelltech.com.
loophole lawyer
6 months ago
More than meets the eye with this company. Wondering if most ( or all) of the IT is done in Europe ( check out the website)β¦β¦
Grant G. Miller Joins Board of MultiCell Technologies Inc.
Published: Oct 23, 2012
SAN DIEGO, Oct. 22, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (MCET.OB), a clinical-stage biopharmaceutical company, has added Grant G. Miller to its board of directors. Mr. Miller will replace Mr. Altig who will be stepping down to allow for this appointment.
Mr. Miller received his B.A. from Loma Linda University in Riverside, CA and an MBA; Finance from the University of San Diego, in San Diego, CA. Mr. Miller currently serves as Chief Financial & Operating Officer of Sandel Avionics and has previously served as Chief Financial Officer of Rapid Bridge, LLC, General Manager & Division Controller of Scubapro, Chief Financial Officer of USA Broadband, Inc., Chief Financial Officer & Senior VP Operations of Alitum, and held several positions with WorldXchange and Time Warner Cable, including International Director of Development in Spain and Portugal, Regional Vice President Finance, Corporate Mergers & Acquisitions Analyst, Manager, Finance and Information Systems and Financial Analysis.
Jerry Newmin, MultiCell's CEO, said, "Mr. Miller was chosen because of his diverse international financial experience and expertise. Mr. Miller brings experience that should help the Company increase values for our shareholders."
MultiCell is developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, and cancer. For more information about MultiCell Technologies, please visit http://www.multicelltech.com.B